These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37417299)

  • 21. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.
    Yang ZQ; Liu G; Bollig-Fischer A; Haddad R; Tarca AL; Ethier SP
    Int J Cancer; 2009 Oct; 125(7):1613-21. PubMed ID: 19569235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of SFRP1 expression is associated with aberrant beta-catenin distribution and tumor progression in mucoepidermoid carcinoma of salivary glands.
    Lee CH; Hung YJ; Lin CY; Hung PH; Hung HW; Shieh YS
    Ann Surg Oncol; 2010 Aug; 17(8):2237-46. PubMed ID: 20162454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].
    Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-26a-5p Suppresses Wnt/
    Yu J; Ge Z; Chen S; Li S; Zhang X; Hu J; Guo W; Wang Y
    Dis Markers; 2022; 2022():7926483. PubMed ID: 35860691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsa_circ_0001445 works as a cancer suppressor via miR-576-5p/SFRP1 axis regulation in ovarian cancer.
    Wu Y; Zhou J; Li Y; Shi X; Shen F; Chen M; Chen Y; Wang J
    Cancer Med; 2023 Mar; 12(5):5736-5750. PubMed ID: 36259450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.
    García-Tobilla P; Solórzano SR; Salido-Guadarrama I; González-Covarrubias V; Morales-Montor G; Díaz-Otañez CE; Rodríguez-Dorantes M
    Gene; 2016 Nov; 593(2):292-301. PubMed ID: 27570179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.
    Sogabe Y; Suzuki H; Toyota M; Ogi K; Imai T; Nojima M; Sasaki Y; Hiratsuka H; Tokino T
    Int J Oncol; 2008 Jun; 32(6):1253-61. PubMed ID: 18497987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H3K27me3 Inactivates SFRP1 to Promote Cell Proliferation via Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Zhou M; Yu S; Liu Y; Shu S; Xu Y; Liu M; Ge Y; Fan H
    Dig Dis Sci; 2023 Jun; 68(6):2463-2473. PubMed ID: 36933113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
    Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
    Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer.
    Zhao CH; Bu XM; Zhang N
    World J Gastroenterol; 2007 Apr; 13(15):2214-7. PubMed ID: 17465504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
    Zeller C; Dai W; Steele NL; Siddiq A; Walley AJ; Wilhelm-Benartzi CS; Rizzo S; van der Zee A; Plumb JA; Brown R
    Oncogene; 2012 Oct; 31(42):4567-76. PubMed ID: 22249249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.
    Strzelczyk JK; Krakowczyk Ł; Owczarek AJ
    Arch Oral Biol; 2019 Feb; 98():265-272. PubMed ID: 30576962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.